Sandoz And Ares Extend AMR Collaboration Ahead Of Next Phase
Initial December 2018 Agreement Extended Until January 2025
With plans to enable genomic surveillance for antimicrobial resistant pathogens using Ares’ next-generation sequencing and bioinformatics technologies, the OpGen subsidiary and Sandoz have shaken hands on an extension to their initial master services agreement.
